To ask the Secretary of State for Health and Social Care, what long-term plans for investment in the domestic diagnostics industry he has made to help ensure that the necessary (a) relationships, (b) infrastructure and (c) supply chains are in place for the UK’s future health security.
The UK Health Security Agency is building surveillance capacity in the Centre for Pandemic Preparedness and working with NHS England and NHS Improvement’s pathology networks, to ensure that diagnostic facilities and supply chains are prepared for future pandemics. We will prepare and maintain the capability to deploy testing and other tools, such as laboratory infrastructure, to be used against a new variant.
We have also committed to invest £2.3 billion through NHS England and NHS Improvement’s National Diagnostic Programme to support the launch of more than 100 community diagnostics centres and supplement further capacity in the pathology network. Through Innovate UK, the Government has supported 155 diagnostic businesses in the United Kingdom. The Medicines and Diagnostics Manufacturing Transformation Fund and Life Sciences Innovation Manufacturing Fund will further support and incentivise domestic diagnostics manufacturing.